Ignite Creation Date:
2024-05-05 @ 9:52 PM
Last Modification Date:
2024-10-26 @ 10:10 AM
Study NCT ID:
NCT00982657
Status:
TERMINATED
Last Update Posted:
2015-11-20
First Post:
2009-09-22
Brief Title:
A Trial Of CVX-060 An Anti-Angiogenic COVX-Body In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma
Sponsor:
Pfizer
Organization:
Pfizer
Organization Data
Organization:
Pfizer
Class:
INDUSTRY
Study ID:
B1131001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None